Lessons from a qualitative study of treatment experiences and perceptions in people with haemophilia in France

Castet, Sabine-Marie; Sepot-Boucherit, Lola; Beranger, Nicolas; Delienne, Stephanie; Chamouard, Valérie

Lessons from a qualitative study of treatment experiences and perceptions in people with haemophilia in France

The Journal of Haemophilia Practice

Volume 12 (2025): Issue 1 (January 2025)

By:

Sabine-Marie Castet

, Lola Sepot-Boucherit

, Nicolas Beranger

, Stephanie Delienne and Valérie Chamouard

Open Access

|Apr 2025

References

Berntorp E, Fischer K, Hart DP, et al. Haemophilia. Nat Rev Dis Primers 2021; 7(1): 45. doi: 10.1038/s41572-021-00278-x.
Open DOI Search in Google Scholar Back to article
Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 2003; 361(9371): 1801–1809. doi: 10.1016/S0140-6736(03)13405-8.
Open DOI Search in Google Scholar Back to article
Morfini M, Haya S, Tagariello G, et al. European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia 2007; 13(5): 606–612. doi: 10.1111/j.1365-2516.2007.01518.x.
Open DOI Search in Google Scholar Back to article
Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003; 102(7): 2358–2363. doi: 10.1182/blood-2003-03-0941.
Open DOI Search in Google Scholar Back to article
Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia 2020; 26: 1–158. doi: 10.1111/hae.14046.
Open DOI Search in Google Scholar Back to article
Morfini M, Zanon E. Emerging drugs for the treatment of hemophilia A and B. Expert Opin Emerg Dr 2016; 21(3): 301–313. doi: 10.1080/14728214.2016.1220536.
Open DOI Search in Google Scholar Back to article
Blair HA. Emicizumab: a review in haemophilia A. Drugs 2019; 79(15): 1697–1707. doi: 10.1007/s40265-019-01200-2.
Open DOI Search in Google Scholar Back to article
Chamouard V, Freyssenge J, Duport G, et al. Evaluation of the care pathway in the context of the dispensing of emicizumab (Hemlibra) in community and hospital pharmacies in France: A patient satisfaction survey. Haemophilia 2023; 29(6): 1490–1498. doi: 10.1111/hae.14857.
Open DOI Search in Google Scholar Back to article
Hermans C, Makris M. Disruptive technology and hemophilia care: The multiple impacts of emicizumab. Res Pract Thromb Haemost 2021; 5(4): e12508. doi: 10.1002/rth2.12508.
Open DOI Search in Google Scholar Back to article
Thornburg CD, Duncan NA. Treatment adherence in hemophilia. Patient Prefer Adherence 2017: 11: 1677–1686. doi: 10.2147/PPA.S139851.
Open DOI Search in Google Scholar Back to article
Vidal. Hemophilia A: Hemlibra available in the city. 2021. Available from https://www.vidal.fr/actualites/27284-hemophilie-a-mise-a-disposition-en-ville-d-hemlibra.html (accessed March 2024).
Search in Google Scholar Back to article
Chamouard V, Fraticelli L, Freyssenge J, et al. Phareo study: Perceived and observed accessibility to therapeutic drugs used for treating patients with inherited bleeding disorders. J Clin Pharm Ther 2022; 47(10): 1667–1675. doi: 10.1111/jcpt.13718.
Open DOI Search in Google Scholar Back to article
Leroy V, Freyssenge J, Renard F, Tazarourte K, Négrier C, Chamouard V. Access to treatment among persons with hemophilia: a spatial analysis assessment in the Rhone-Alpes region, France. J Am Pharm Assoc 2019; 59(6): 797–803. doi: 10.1016/j.japh.2019.07.006.
Open DOI Search in Google Scholar Back to article
Frybourg S, Remuzat C, Kornfeld Å, Toumi M. Conflict of interest in Health Technology Assessment decisions: case law in France and impact on reimbursement decisions. J Mark Access Health Policy 2015; 3(1): 25682. doi: 10.3402/jmahp.v3.25682.
Open DOI Search in Google Scholar Back to article
Savage J. Ethnography and health care. Br Med J 2000; 321(7273): 1400–1402. doi: 10.1136/bmj.321.7273.1400.
Open DOI Search in Google Scholar Back to article
Strudwick RM. Ethnographic research in healthcare – patients and service users as participants. Disabil Rehabil 2021; 43(22): 3271–3275. doi: 10.1080/09638288.2020.1741695.
Open DOI Search in Google Scholar Back to article
Grain Intelligence Inc. Grain. 2023. Available from https://grain.com/ (accessed 2023).
Search in Google Scholar Back to article
QSR International. NVIVO. Version 14, 2023. Available from https://help-nv.qsrinternational.com/14/win/Content/about-nvivo/about-nvivo.htm (accessed April 2023).
Search in Google Scholar Back to article
Hughes T, Brok-Kristensen M, Gargeya Y, et al. Navigating uncertainty: an examination of how people with haemophilia understand and cope with uncertainty in protection in an ethnographic study. J Haem Pract 2020; 7(1): 158–164. doi: 10.17225/jhp00168.
Open DOI Search in Google Scholar Back to article
Hughes T, Brok-Kristensen M, Gargeya Y, et al. “What more can we ask for?”: an ethnographic study of challenges and possibilities for people living with haemophilia. J Haem Pract 2020; 7(1): 25–36. doi: 10.17225/jhp00151.
Open DOI Search in Google Scholar Back to article
Tischer B, Marino R, Napolitano M. Patient preferences in the treatment of hemophilia A: impact of storage conditions on product choice. Patient Prefer Adherence 2018; 12: 431–441. doi: 10.2147/PPA.S151812.
Open DOI Search in Google Scholar Back to article
Fornari A, Antonazzo IC, Rocino A, et al. The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey. Haemophilia 2024; 30(2): 449–462. doi: 10.1111/hae.14926.
Open DOI Search in Google Scholar Back to article
Wiley RE, Khoury CP, Snihur AW, et al. From the voices of people with haemophilia A and their caregivers: challenges with current treatment, their impact on quality of life and desired improvements in future therapies. Haemophilia 2019; 25(3): 433–440. doi: 10.1111/hae.13754.
Open DOI Search in Google Scholar Back to article
Garcia VC, Mansfield C, Pierce A, Leach C, Smith JC, Afonso M. Patient and caregiver preferences for haemophilia treatments: A discrete-choice experiment. Haemophilia 2024; 30(2): 375–387. doi: 10.1111/hae.14928.
Open DOI Search in Google Scholar Back to article
von der Lippe C, Frich JC, Harris A, Solbrække KN. Treatment of hemophilia: a qualitative study of mothers’ perspectives. Pediatric Blood Cancer 2017; 64(1): 121–127. doi: 10.1002/pbc.26167.
Open DOI Search in Google Scholar Back to article
Ballmann J, Ewers M. Nurse-led education of people with bleeding disorders and their caregivers: A scoping review. Haemophilia 2022; 28(6): e153–e163. doi: 10.1111/hae.14629.
Open DOI Search in Google Scholar Back to article
Schrijvers L, Bedford M, Elfvinge P, Andritschke K, Leenders B, Harrington C. The role of the European haemophilia nurse. J Haem Pract 2014; 1(1): 24–27. doi: 10.17225/jhp.00008.
Open DOI Search in Google Scholar Back to article
Hermans C, Pierce GF. Towards achieving a haemophilia-free mind. Haemophilia 2023; 29(4): 951–953. doi: 10.1111/hae.14807.
Open DOI Search in Google Scholar Back to article
Hughes T, Brok-Kristensen M, Gargeya Y, et al. “He’s a normal kid now”: an ethnographic study of challenges and possibilities in a new era of haemophilia care. J Haem Pract 2020; 7(1): 150–157. doi: 10.17225/jhp00167.
Open DOI Search in Google Scholar Back to article
Mannucci P. AIDS, hepatitis and hemophilia in the 1980s: memoirs from an insider. J Thromb Haemost 2003; 1(10): 2065–2069. doi: 10.1046/j.1538-7836.2003.00483.x.
Open DOI Search in Google Scholar Back to article
Potì S, Palareti L, Emiliani F, Rodorigo G, Valdrè L. The subjective experience of living with haemophilia in the transition from early adolescence to young adulthood: the effect of age and the therapeutic regimen. Int J Adolesc Youth 2018; 23(2): 133–144. doi: 10.1080/02673843.2017.1299017.
Open DOI Search in Google Scholar Back to article
duTreil S. Physical and psychosocial challenges in adult hemophilia patients with inhibitors. J Blood Med 2014: 5: 115–122. doi: 10.2147/JBM.S63265.
Open DOI Search in Google Scholar Back to article
Recht M, Konkle B, Jackson S, Neufeld E, Rockwood K, Pipe S. Recognizing the need for personalization of haemophilia patient-reported outcomes in the prophylaxis era. Haemophilia 2016; 22(6): 825–832. doi: 10.1111/hae.13066.
Open DOI Search in Google Scholar Back to article
Krumb E, Hermans C. Living with a “hemophilia-free mind” – The new ambition of hemophilia care? Res Pract Thromb Haemost 2021; 5(5): e12567. doi: 10.1002/rth2.12567.
Open DOI Search in Google Scholar Back to article
Forsyth A, Gregory M, Nugent D, et al. Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics. Haemophilia 2014; 20(1): 44–51. doi: 10.1111/hae.12239.
Open DOI Search in Google Scholar Back to article
Goodson L, Vassar M. An overview of ethnography in healthcare and medical education research. J Educ Eval Health Prof 2011; 8: 4. doi: 10.3352/jeehp.2011.8.4.
Open DOI Search in Google Scholar Back to article

DOI: https://doi.org/10.2478/jhp-2025-0006 | Journal eISSN: 2055-3390

Journal RSS Feed

Language: English

Page range: 48 - 56

Published on: Apr 12, 2025

Published by: Haemnet Ltd

In partnership with: Paradigm Publishing Services

Publication frequency: 1 times per year

Keywords:

Haemophilia,

Ethnographic interviews,

Unmet needs,

Treatment perceptions,

Emicizumab,

Factor replacement therapy

Related subjects:

Medicine,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Clinical medicine, other,

Pharmacy,

Pharmacology

© 2025 Sabine-Marie Castet, Lola Sepot-Boucherit, Nicolas Beranger, Stephanie Delienne, Valérie Chamouard, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 12 (2025): Issue 1 (January 2025)Next article